Demand for Hospital Acquired Infections Therapeutics in UK

Table of Content

1. Executive Summary
   • UK Market Outlook
   • Demand to side Trends
   • Supply to side Trends
   • Technology Roadmap Analysis
   • Analysis and Recommendations
2. Market Overview
   • Market Coverage / Taxonomy
   • Market Definition / Scope / Limitations
3. Market Background
   • Market Dynamics
     • Drivers
     • Restraints
     • Opportunity
     • Trends
   • Scenario Forecast
     • Demand in Optimistic Scenario
     • Demand in Likely Scenario
     • Demand in Conservative Scenario
   • Opportunity Map Analysis
   • Product Life Cycle Analysis
   • Supply Chain Analysis
   • Investment Feasibility Matrix
   • Value Chain Analysis
   • PESTLE and Porter’s Analysis
   • Regulatory Landscape
   • Regional Parent Market Outlook
   • Production and Consumption Statistics
   • Import and Export Statistics
4. UK Market Analysis 2020 to 2024 and Forecast, 2025 to 2035
   • Historical Market Size Value (USD Million) Analysis, 2020 to 2024
   • Current and Future Market Size Value (USD Million) Projections, 2025 to 2035
     • Y to o to Y Growth Trend Analysis
     • Absolute $ Opportunity Analysis
5. UK Market Pricing Analysis 2020 to 2024 and Forecast 2025 to 2035
6. UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Drug Class
   • Introduction / Key Findings
   • Historical Market Size Value (USD Million) Analysis By Drug Class, 2020 to 2024
   • Current and Future Market Size Value (USD Million) Analysis and Forecast By Drug Class, 2025 to 2035
     • Antibacterial Drugs
     • Antiviral Drugs
     • Antifungal Drugs
   • Y to o to Y Growth Trend Analysis By Drug Class, 2020 to 2024
   • Absolute $ Opportunity Analysis By Drug Class, 2025 to 2035
7. UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Infection Type
   • Introduction / Key Findings
   • Historical Market Size Value (USD Million) Analysis By Infection Type, 2020 to 2024
   • Current and Future Market Size Value (USD Million) Analysis and Forecast By Infection Type, 2025 to 2035
     • Surgical Site Infections
     • Urinary Tract Infections
     • Ventilator-associated Pneumonia
     • Bloodstream Infections
     • Other HAIs
   • Y to o to Y Growth Trend Analysis By Infection Type, 2020 to 2024
   • Absolute $ Opportunity Analysis By Infection Type, 2025 to 2035
8. UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
   • Introduction
   • Historical Market Size Value (USD Million) Analysis By Region, 2020 to 2024
   • Current Market Size Value (USD Million) Analysis and Forecast By Region, 2025 to 2035
     • UK
   • Market Attractiveness Analysis By Region
9. UK Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Country
   • Historical Market Size Value (USD Million) Trend Analysis By Market Taxonomy, 2020 to 2024
   • Market Size Value (USD Million) Forecast By Market Taxonomy, 2025 to 2035
     • By Country
     • By Drug Class
     • By Infection Type
   • Market Attractiveness Analysis
     • By Country
     • By Drug Class
     • By Infection Type
   • Key Takeaways
10. Market Structure Analysis
    • Competition Dashboard
    • Competition Benchmarking
    • Market Share Analysis of Top Players
      • By Regional
      • By Drug Class
      • By Infection Type
11. Competition Analysis
    • Competition Deep Dive
      • Merck & Co., Inc.
        • Overview
        • Product Portfolio
        • Profitability by Market Segments (Product/Age /Sales Channel/Region)
        • Sales Footprint
        • Strategy Overview
          • Marketing Strategy
          • Product Strategy
          • Channel Strategy
      • Pfizer Inc.
      • Bayer AG
      • GlaxoSmithKline Plc
      • Daiichi Sankyo Company, Limited
      • AbbVie Inc.
      • F. Hoffmann-La Roche Ltd
      • Allergan Plc
      • Abbott Laboratories
      • Sanofi S.A.
12. Assumptions & Acronyms Used
13. Research Methodology